Buscar
Mostrando ítems 1-10 de 481
Evaluation of the Mycobacterium tuberculosis cell wall lipid-induced response in individuals with pulmonary tuberculosis
(Sociedade Brasileira de Medicina Tropical, 2017)
Bacille Calmette Guérin (BCG) and new TB vaccines: specific, cross-myco‐ bacterial and off-target effects
The Bacille Calmette Guérin (BCG) vaccine was developed over a century ago and has become one of the most used vaccines without undergoing a modern vaccine development life cycle. Despite this, the vaccine has protected ...
Prevalência de TB ativa e TB latente em internos de um hospital penal na Bahia
(2009)
OBJETIVO: Estimar as prevalências de TB latente e TB ativa entre custodiados de um hospital penal na Bahia.
MÉTODOS: Foram avaliados através de estudo de corte transversal com coleta prospectiva de dados 237 internos no ...
LATENT TUBERCULOSIS AMONG PRISON INMATES IN THE BRAZILIAN MID-WESTTUBERCULOSE LATENTE EM INDIVÍDUOS DE UMA UNIDADE PRISIONAL DO CENTRO OESTE DO BRASIL
(Universidade Federal de Goiás, 2016)
Prevalence of positive TST among healthcare workers in high-burden TB setting in Peru
(BioMed Central, 2020)
Background: Tuberculosis (TB) transmission has long been recognized as an important occupational hazard for healthcare workers (HCWs). HCWs have a 5.8% annual risk of exposure and three times greater risk of developing ...
Pulmonary tuberculosis after therapy with anti-tumor necrosis factor (Tnf) for crohn disease: A case report
(2021-01-01)
Background: Challenging differential diagnosis Adalimumab is a biological anti-tumor necrosis factor (TNF) agent which induces and maintains remission in patients with moderate-to-severe Crohn disease (CD). An adverse ...